Clinical Trials Logo

Clinical Trial Summary

The purpose of this research is to assess the association between diet and pulmonary function during standardized EIB testing. Determine the effect of Vitamin C supplementation on airway inflammatory markers and bronchoconstriction after a standardized EIB test compared to usual diet and placebo control.


Clinical Trial Description

This study will use a double-blind, randomized, cross-over design with subjects serving as their own controls. This study will be conducted over a consecutive five-week period.

All subjects will be asked to discontinue taking their short- and long-acting beta-agonist medication 12 and 24 hours respectively prior to data collection. Also, all subjects will be asked to refrain from caffeine, physical activity, and NSAID use 24 hours prior to testing. In addition all subjects will be asked to abstain from taking any vitamin supplement during the course of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03610932
Study type Interventional
Source University of Kansas Medical Center
Contact
Status Withdrawn
Phase N/A
Start date July 1, 2018
Completion date May 3, 2019

See also
  Status Clinical Trial Phase
Withdrawn NCT00375232 - Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes N/A
Completed NCT00085774 - Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma Phase 3
Completed NCT00268723 - Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIB Phase 3
Completed NCT00701025 - Mechanisms of Exercise-induced Bronchospasm
Withdrawn NCT00662779 - Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB) Phase 3